NCT00442559View on ClinicalTrials.gov

Montelukast in Mild Asthmatic Children With Allergic Rhinitis (0476-367)

PHASE4CompletedINTERVENTIONAL
Enrollment

191

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions
AsthmaAllergic Rhinitis
Interventions
DRUG

montelukast sodium

Montelukast 4/5 mg tablet (oral chewable), once daily, 12 weeks to up to 12 months

DRUG

inhaled corticosteroid

Inhaled corticosteroid solution, 1-4 puffs daily, 12 weeks to up to 12 months

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00442559 - Montelukast in Mild Asthmatic Children With Allergic Rhinitis (0476-367) | Biotech Hunter | Biotech Hunter